Physician profile
Beth A Kus
NPI 1972659217
$3,740.08
in general payments reported to CMS, 2019-2025
10 companies · $986 in 2025
The $986 reported for 2025 was more than what 80% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $773 · 2022: $538 · 2023: $784 · 2024: $659 · 2025: $986.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,429.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,428.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,029.44 | 2021-2025 | |
| Lundbeck LLC | $338.43 | 2023-2025 | Vyepti |
| Teva Pharmaceuticals USA, INC. | $327.95 | 2021-2025 | Ajovy |
| Pfizer INC. | $298.81 | 2023-2025 | |
| Biohaven Pharmaceuticals, INC. | $246.82 | 2021 | |
| Lilly USA, LLC | $130.05 | 2021-2025 | Emgality, Kisunla |
| Amgen INC. | $121.37 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $120.72 | 2022 | |
| Allergan, INC. | $112.11 | 2021 | |
| Currax Pharmaceuticals LLC | $14.38 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beth Kus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.